Combined therapy of diabetic peripheral neuropathy with breviscapine and mecobalamin: A systematic review and a meta-analysis of Chinese studies

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Zheng, Chanjiao ^a   Ou, Weilin ^a   Shen, Huanyu ^a   Zhou, Zhiheng ^a   Wang, Jiaji ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BREVISCAPINE; MECOBALAMIN; CYANOCOBALAMIN; FLAVONOID;

CLINICAL PRACTICE; DIABETIC NEUROPATHY; DIABETIC PERIPHERAL NEUROPATHY; DIET THERAPY; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG TOLERANCE; DRUG WITHDRAWAL; HEART PALPITATION; HUMAN; KINESIOTHERAPY; META ANALYSIS; NAUSEA; NERVE CONDUCTION; NONHUMAN; PERIPHERAL NEUROPATHY; PRURITUS; PUBLISHING; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TREATMENT DURATION; ANALOGS AND DERIVATIVES; CHINA; COMPARATIVE STUDY; DIABETIC NEUROPATHIES; DRUG COMBINATION; FEMALE; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

CHINA; DIABETIC NEUROPATHIES; DRUG THERAPY, COMBINATION; FEMALE; FLAVONOIDS; HUMANS; MALE; VITAMIN B 12;

EID: 84926500193     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/680756     Document Type: Review

References (52)

1. G. Deli, E. Bosnyak, G. Pusch, S. Komoly, and G. Feher, "Diabetic neuropathies: diagnosis and management," Neuroendocrinology, Vol. 98, no. 4, pp. 267-280, 2014.
2. A. J. M. Boulton, A. I. Vinik, J. C. Arezzo et al., "Diabetic neuropathies: a statement by the American Diabetes Association," Diabetes Care, Vol. 28, no. 4, pp. 956-962, 2005.
3. M. C. Spruce, J. Potter, and D. V. Coppini, "The pathogenesis and management of painful diabetic neuropathy: a review," Diabetic Medicine, Vol. 20, no. 2, pp. 88-98, 2003.
4. S. Tesfaye and D. Selvarajah, "Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy," Journal of Endocrinological Investigation, Vol. 35, no. 4, pp. 434-448, 2012.
5. A. Gordois, P. Scuffham, A. Shearer, A. Oglesby, and J. A. Tobian, "The health care costs of diabetic peripheral neuropathy in the U.S.," Diabetes Care, Vol. 26, no. 6, pp. 1790-1795, 2003.
6. J. L. Edwards, A. M. Vincent, H. T. Cheng, and E. L. Feldman, "Diabetic neuropathy: mechanisms to management," Pharmacology and Therapeutics, Vol. 120, no. 1, pp. 1-34, 2008.
7. A. M. Vincent, B. C. Callaghan, A. L. Smith, and E. L. Feldman, "Diabetic neuropathy: cellular mechanisms as therapeutic targets," Nature Reviews Neurology, Vol. 7, no. 10, pp. 573-583, 2011.
8. P. Fernyhough, S. K. R. Chowdhury, and R. E. Schmidt, "Mitochondrial stress and the pathogenesis of diabetic neuropathy," Expert Review of Endocrinology & Metabolism, Vol. 5, no. 1, pp. 39-49, 2010.
9. P. A. Low, K. K. Nickander, and H. J. Tritschler, "The roles of oxidative stress and antioxidant. Treatment in experimental diabetic neuropathy," Diabetes, Vol. 46, supplement 2, pp. S38-S42, 1997.
10. N. E. Cameron, S. E. M. Eaton, M. A. Cotter, and S. Tesfaye, "Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy," Diabetologia, Vol. 44, no. 11, pp. 1973-1988, 2001.
11. C.-Z. Hao, F. Wu, L. Lu et al., "Chinese herbal medicine for diabetic peripheral neuropathy: an updated meta-analysis of 10 high-quality randomized controlled studies," PLoS ONE, Vol. 8, no. 10, Article ID e76113, 2013.
12. Y. Sun, M.-S. Lai, and C.-J. Lu, "Effectiveness of vitamin B12 on diabetic neuropathy: systematic review of clinical controlled trials," Acta Neurologica Taiwanica, Vol. 14, no. 2, pp. 48-54, 2005.
13. S. Wang, H. Wang, H. Guo, L. Kang, X. Gao, and L. Hu, "Neuroprotection of Scutellarin is mediated by inhibition of microglial inflammatory activation," Neuroscience, Vol. 185, pp. 150-160, 2011.
14. 2+-cycling proteins in streptozotocin-induced diabetic rats," Acta Diabetologica, Vol. 47, no. 1, supplement, pp. S209-S218, 2010.
15. C. Guo, Y. Zhu, Y. Weng et al., "Therapeutic time window and underlying therapeutic mechanism of breviscapine injection against cerebral ischemia/reperfusion injury in rats," Journal of Ethnopharmacology, Vol. 151, no. 1, pp. 660-666, 2014.
16. J. Zhang, X. S. Li, and W. D. Zhang, "The advance in studies on chemical component and pharmacology of Erigeron breviscapus," Journal of Pharmaceutical Practice, Vol. 20, no. 2, pp. 103-107, 2002.
17. J. M. Cui and S. Wu, "The advance on the research of breviscapine," Natural Product Research and Development, Vol. 15, no. 3, pp. 255-258, 2003.
18. M. Li, Y. Zheng, F.-Y. Shan, J. Zhou, T. Gong, and Z.-R. Zhang, "Development of ionic-complex-based nanostructured lipid carriers to improve the pharmacokinetic profiles of breviscapine," Acta Pharmacologica Sinica, Vol. 34, no. 8, pp. 1108-1115, 2013.
19. H. Hong and G.-Q. Liu, "Protection against hydrogen peroxide-induced cytotoxicity in PC12 cells by scutellarin," Life Sciences, Vol. 74, no. 24, pp. 2959-2973, 2004.
20. H. Hong and G.-Q. Liu, "Scutellarin attenuates oxidative glutamate toxicity in PC12 cells," Planta Medica, Vol. 70, no. 5, pp. 427-431, 2004.
21. K. A. Head, "Peripheral neuropathy: pathogenic mechanisms and alternative therapies," Alternative Medicine Review, Vol. 11, no. 4, pp. 294-329, 2006.
22. V. A. Fonseca, L. A. Lavery, T. K. Thethi et al., "Metanx in type 2 diabetes with peripheral neuropathy: a randomized trial," The American Journal of Medicine, Vol. 126, no. 2, pp. 141-149, 2013.
23. B. A. Yaqub, A. Siddique, and R. Sulimani, "Effects of methylcobalamin on diabetic neuropathy," Clinical Neurology and Neurosurgery, Vol. 94, no. 2, pp. 105-111, 1992.
24. H. Ide, S. Fujiya, Y. Asanuma, M. Tsuji, H. Sakai, and Y. Agishi, "Clinical usefulness of intrathecal injection of methylcobalamin in patients with diabetic neuropathy," Clinical Therapeutics, Vol. 9, no. 2, pp. 183-192, 1987.
25. Y. S. Shi, Y. Yuan, P. Zhang et al., "Breviscapine injection the treatment of diabetic peripheral neuropathy of 45 cases," Chinese Journal of Experimental Traditional Medical Formulae, Vol. 19, no. 23, pp. 274-277, 2013.
26. H. P. Lan and F. Q. Wu, "Therapeutic efficacy of Breviscapine in combination with mecobalamin in Diabetic Peripheral Neuropathy," Chinese Journal of Rural Medicine and Pharmacy, Vol. 17, no. 1, pp. 34-35, 2010.
27. World Health Organization, Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus, World Health Organization, Geneva, Switzerland, 1999.
28. H. Li, Z. B. Li, and G. T. Liang, "Clinical efficacy of combined therapy of diabetic peripheral neuropathy with fleabane injection and mecobalam: an analysis of 64 cases," Hebei Journal of Traditional Chinese Medicine, Vol. 31, no. 4, pp. 605-606, 2009.
29. L. J. Chang, "Therapeutic efficacy of fleabane in combination with mecobalamin in diabetic peripheral neuropathy," Chinese Journal of Practical Nervous Diseases, Vol. 10, no. 9, pp. 120-122, 2007.
30. G. Chen and K. Shao, "Therapy of in Diabetic Peripheral Neuropathy with fleabane injection and mecobalamin: an analysis of 68 cases," Forum on Traditional Chinese Medicine, Vol. 23, no. 6, article 40, 2008.
31. Y. F. Duan and X. H. Yan, "Therapy of diabetic peripheral neuropathy with fleabane injection and methycobal injection: an analysis of 36 cases," Central Plains Medical Journal, Vol. 31, no. 2, p. 46, 2004.
32. B. Feng, F. L. Sun, W. H. Feng et al., "Clinical study of combined treatment with breviscapine and mecobalamin on diabetic peripheral neuropathy in the elderly with DM," Chinese Journal of Natural Medicines, Vol. 209, no. 5, pp. 372-374, 2009.
33. L. Jin, H. S. Xu, L. S. Tian et al., "Effects of therapy of breviscapine combined with mecobalamin on diabetic peripheral neuropathy," China Practical Medicine, Vol. 5, no. 17, pp. 26-27, 2010.
34. H. P. Lan, F. Q. Wu, L. L. Tian et al., "Clinical efficacy of combined therapy of diabetic peripheral neuropathy with breviscapine and mecobalam," Modern Journal of Integrated Traditional Chinese and Western Medicine, Vol. 16, no. 31, pp. 4641-4642, 2007.
35. W. G. Li, J. Z. Ma, X. H. Tian et al., "Clinical efficacy of combined therapy of diabetic peripheral neuropathy with fleabane and mecobalamin," Xinjiang Medical Journal, Vol. 36, no. 4, pp. 21-22, 2006.
36. C. S. Luo and Y. Tang, "Clinical application of breviscapine combined with mecobalamin in the treatment of diabetic peripheral neuropathy," Journal of Clinical Research, Vol. 30, no. 3, pp. 530-532, 2013.
37. Y. H. Peng, H. L. Zeng, Y. Cai et al., "Clinical effect analysis of breviscapine and methylcobalam on diabetic peripheral neuropathy," Journal of Clinical and Experimental Medicine, Vol. 11, no. 13, pp. 1003-1005, 2012.
38. L. P. Sun, "Therapeutic efficacy of breviscapine in combination with methycobal in diabetic peripheral neuropathy," Journal of Practical Diabetology, no. 3, pp. 32-33, 2014.
39. F. Q. Wang, "Therapeutic efficacy of breviscapine injection in combination with methycobal in 34 cases of diabetic peripheral neuropathy," Shaanxi Journal of Traditional Chinese Medicine, Vol. 34, no. 7, pp. 825-826, 2013.
40. H. X. Wu and X. Zhang, "Therapeutic efficacy of fleabane in combination with methycobal in 38 cases of diabetic peripheral neuropathy," Chinese Journal of Practical Nervous Diseases, Vol. 10, no. 52, pp. 103-104, 2007.
41. H. M. Zhang, "Therapeutic efficacy of breviscapine and mecobalamin in diabetic peripheral neuropathy: a clinical analysis," China Foreign Medical Treatment, Vol. 31, no. 19, p. 97, 2012.
42. D. L. Zhou, "Combined therapy of diabetic peripheral neuropathy with breviscapine and mecobalamin," China Modern Doctor, Vol. 47, no. 4, pp. 79-80, 2009.
43. D. R. Whiting, L. Guariguata, C. Weil, and J. Shaw, "IDF Diabetes Atlas: global estimates of the prevalence of diabetes for 2011 and 2030," Diabetes Research and Clinical Practice, Vol. 94, no. 3, pp. 311-321, 2011.
44. P. J. Dyck, K. M. Kratz, J. L. Karnes et al., "The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study," Neurology, Vol. 43, no. 4, pp. 817-824, 1993.
45. J. Eichberg, "Protein kinase C changes in diabetes: is the concept relevant to neuropathy?" International Review of Neurobiology, Vol. 50, pp. 61-82, 2002.
46. N. E. Cameron and M. A. Cotter, "Metabolic and vascular factors in the pathogenesis of diabetic neuropathy," Diabetes, Vol. 46, no. 2, pp. S31-S37, 1997.
47. P. A. Low, T. D. Lagerlund, and P. G. McManis, "Nerve blood flow and oxygen delivery in normal, diabetic, and ischemic neuropathy," International Review of Neurobiology, Vol. 31, pp. 355-438, 1989.
48. D. H. Xie, "Advances in the clinical application of breviscapine," New Medicine, Vol. 38, no. 6, pp. 408-410, 2007.
49. J. Li, L. Zhang, and S. Zhao, "Meta analysia of alpha-lipoic acid and mecobalamin in the treatment of diabetic peripheral neuropathy," China Medical Herald, Vol. 10, no. 3, pp. 88-90, 2013.
50. X. D. Liu, Dreviscapine for Diabetic Peripheral Neuropathy: A Systematic Review, Guangxi Medical University, 2010.
51. H. Hu, H. Li, F.-P. Zheng, Y. Cheng, J. Miao, and W. Zhang, "A comparison of clinical effectiveness of different neuropathy scoring systems in screening asymptomatic diabetic peripheral neuropathy," Chinese Journal of Internal Medicine, Vol. 1, no. 51, pp. 13-17, 2012.
52. Cooperative Group of Multi-center Clinical Study in Shanghai, "A pilot study on the therapy of diabetic peripheral neuropathy with mecobalamin," Chinese Journal of Endocrinology and Metabolism, Vol. 13, no. 4, pp. 197-200, 1997.